Levodopa/carbidopa/entacapone versus levodopa/benserazide plus pramipexole in Chinese patients with Parkinson’s disease experiencing wearing off
LCE and LB + PPX were both effective, safe and tolerable in treating patients with PD who experienced WO.
Authors
- Yijing Guo (ORCID: https://orcid.org/0000-0002-6638-8963)
- Xianwen Chen (ORCID: https://orcid.org/0000-0001-9262-2568)
- Hui Huang (ORCID: https://orcid.org/0000-0003-3212-0544)
- Cuiyu Yu
- Lihua Shen (ORCID: https://orcid.org/0000-0002-4692-6488)
- Dan Li (ORCID: https://orcid.org/0000-0002-1609-1539)
- Weiguo Liu (ORCID: https://orcid.org/0000-0001-5916-9837)
- Chun‐Feng Liu (ORCID: https://orcid.org/0000-0002-8364-0219)
- Min Ye (ORCID: https://orcid.org/0000-0002-9952-2380)
- Xueling Zhang (ORCID: https://orcid.org/0009-0000-6957-1205)
- Juping Chen (ORCID: https://orcid.org/0000-0003-2077-2414)
- Aiping Gong
- Yang Zhao (ORCID: https://orcid.org/0009-0004-6687-8745)
Institutions
- Nanjing University of Chinese Medicine (CN)
- Huaibei Normal University (CN)
- Xuzhou Medical College (CN)
- Anhui Medical University (CN)
- Nantong University (CN)
- Soochow University (CN)
- Affiliated Hospital of Nantong University (CN)
- Huaibei Mining (China) (CN)
- Zhongda Hospital Southeast University (CN)
- Nanjing Brain Hospital (CN)
- Second Affiliated Hospital of Soochow University (CN)
- Changshu No.1 People's Hospital (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Jiangsu Province Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-11-19
- DOI
- https://doi.org/10.3389/fneur.2025.1682614
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Jiangsu Commission of Health
- National Natural Science Foundation of China
- Government of Jiangsu Province
- Natural Science Foundation of Jiangsu Province